CSBR Champions Oncology, Inc.

NASDAQ
$5.10

Champions Oncology, Inc. (CSBR) is confirmed to report earnings on September 10, 2026, after the market close.

Champions Oncology Reported Earnings
Thursday, September 10, 2026 · 4:00 PM ET
Earnings Date
Sep 10
Thursday · 4:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Champions Oncology, Inc.

Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.

Sector

Healthcare